Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency Patients

about

Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency Patients

Item

http://www.wikidata.org/entity/Q57612649

description

im Mai 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в травні 2018

@uk

name

Rapid Push vs Pump-Infused Sub ...... mary Immunodeficiency Patients

@en

Rapid Push vs Pump-Infused Sub ...... mary Immunodeficiency Patients

@nl

type

Item

label

Rapid Push vs Pump-Infused Sub ...... mary Immunodeficiency Patients

@en

Rapid Push vs Pump-Infused Sub ...... mary Immunodeficiency Patients

@nl

prefLabel

Rapid Push vs Pump-Infused Sub ...... mary Immunodeficiency Patients

@en

Rapid Push vs Pump-Infused Sub ...... mary Immunodeficiency Patients

@nl

P1476

Rapid Push vs Pump-Infused Sub ...... mary Immunodeficiency Patients

@en

P2093

Anne-Laure Fauchais

http://www.w3.org/2001/XMLSchema#string

Antoine Alix

http://www.w3.org/2001/XMLSchema#string

Boris Bienvenu

http://www.w3.org/2001/XMLSchema#string

Cyrille Hoarau

http://www.w3.org/2001/XMLSchema#string

Daniel Antier

http://www.w3.org/2001/XMLSchema#string

Dominique Lachaud

http://www.w3.org/2001/XMLSchema#string

Françoise Renon-Carron

http://www.w3.org/2001/XMLSchema#string

Grégoire Cozon

http://www.w3.org/2001/XMLSchema#string

Jean-Charles Crave

http://www.w3.org/2001/XMLSchema#string

Jean-François Viallard

http://www.w3.org/2001/XMLSchema#string

P2860

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency.

Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases.

Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies.

Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route.

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications.

Subcutaneous immunoglobulin therapy by rapid push is preferred to infusion by pump: a retrospective analysis.

Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis.

Why I use subcutaneous immunoglobulin (SCIG).

Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.

P2888

s10875-018-0507-x

P304

503-512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10875-018-0507-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eric Hachulla

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29855752

http://www.w3.org/2001/XMLSchema#string

P921

immunology

quality of life

P932

6028863

http://www.w3.org/2001/XMLSchema#string